# Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-trial-comparing-axitinib-with-the-combination-of-axitinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johnny Duerinck,Stephanie Du Four,Frank Bouttens,Claire André,Vincent Verschaeve,Frank Van Fraeyenhove,C. Chaskis,Nicky D’Haene,Marie Le Mercier,Anne Rogiers,Alex Michotte,Isabelle Salmon,Bart Neyns |
| Citations | 63 |
| DOI | 10.1007/s11060-017-2629-z |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2762209305 |
| PMID | 28988341 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Vincent Verschaeve](https://scholariq.org/researchers/vincent-verschaeve/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.